Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Moderate to Severe Graves' Orbitopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07152366
What this trial is testing

Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 96
Large-scale testing (Phase 3)UnknownNCT04776993
What this trial is testing

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

Who this might be right for
Graves' Orbitopathy
University of Pisa 52
Large-scale testing (Phase 3)Looking for participantsNCT07753603
What this trial is testing

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease, TEDGraves Orbitopathy
Sling Therapeutics, Inc. 130
Testing effectiveness (Phase 2)Ended earlyNCT03938545
What this trial is testing

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Who this might be right for
Graves' Ophthalmopathy (GO)
Immunovant Sciences GmbH 65
Large-scale testing (Phase 3)UnknownNCT05015127
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Ophthalmopathy
Harbour BioMed (Guangzhou) Co. Ltd. 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603
What this trial is testing

Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Who this might be right for
Graves' Orbitopathy
University of Pisa 102
Large-scale testing (Phase 3)Study completedNCT05276063
What this trial is testing

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 90